Review article · 2023 · Open access
Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
Molecules, 28(3), 1506 · Published 3 February 2023 · DOI 10.3390/molecules28031506
In brief
“Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma” is a 2023 review article by Xiaoyan Yang and 4 co-authors, published in Molecules. OpenAlex counts 14 citations as of 21 November 2026, which puts it in the top 8% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Molecules.
- Citations
- 14
- Most cited in
- 2024 (4)
- Field-weighted impact
- 0.21
- References
- 181
- Authors
- 5
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with an extremely poor prognosis and low survival rate. Due to its inconspicuous symptoms, PDAC is difficult to diagnose early. Most patients are diagnosed in the middle and late stages, losing the opportunity for surgery. Chemotherapy is the main treatment in clinical practice and improves the survival of patients to some extent. However, the improved prognosis is associated with higher side effects, and the overall prognosis is far from satisfactory. In addition to resistance to chemotherapy, PDAC is significantly resistant to targeted therapy and immunotherapy. The failure of multiple treatment modalities indicates great dilemmas in treating PDAC, including high molecular heterogeneity, high drug resistance, an immunosuppressive microenvironment, and a dense matrix. Nanomedicine shows great potential to overcome the therapeutic barriers of PDAC. Through the careful design and rational modification of nanomaterials, multifunctional intelligent nanosystems can be obtained. These nanosystems can adapt to the environment's needs and compensate for conventional treatments' shortcomings. This review is focused on recent advances in the use of well-designed nanosystems in different therapeutic modalities to overcome the PDAC treatment dilemma, including a variety of novel therapeutic modalities. Finally, these nanosystems' bottlenecks in treating PDAC and the prospect of future clinical translation are briefly discussed.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yang, X., Lu, Y., Xu, J., Du, Y., & Yu, R. (2023). Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. Molecules, 28(3), 1506. https://doi.org/10.3390/molecules28031506
MLA 9
Yang, Xiaoyan, et al. “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.” Molecules, vol. 28, no. 3, 2023, p. 1506. https://doi.org/10.3390/molecules28031506.
Chicago
Yang, Xiaoyan, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, and Ri‐Sheng Yu. 2023. “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.” Molecules 28 (3): 1506. https://doi.org/10.3390/molecules28031506.
Harvard
Yang, X. et al. (2023) ‘Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma’, Molecules, 28(3), p. 1506. doi:10.3390/molecules28031506.
IEEE
X. Yang, Y. Lu, J. Xu, Y. Du, and R. Yu, “Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma,” Molecules, vol. 28, no. 3, p. 1506, 2023, doi: 10.3390/molecules28031506.
BibTeX
@article{yang2023recent,
title = {{Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma}},
author = {Yang, Xiaoyan and Lu, Yuan‐Fei and Xu, Jianxia and Du, Yongzhong and Yu, Ri‐Sheng},
journal = {Molecules},
year = {2023},
volume = {28},
number = {3},
pages = {1506},
doi = {10.3390/molecules28031506},
url = {https://doi.org/10.3390/molecules28031506}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 2 | |
| 2024 | 4 | |
| 2025 | 4 | |
| 2026 | 4 |
Its field-weighted citation impact is 0.21: it has been cited 0.21 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- pancreatic ductal adenocarcinoma
- nanomedicine
- drug resistance
- chemoresistance
- immunotherapy resistance
- tumor microenvironment
- immunosuppressive tumor microenvironment
- tumor stroma
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Yang, X., Lu, Y., Xu, J., Du, Y., & Yu, R. (2023). Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. Molecules, 28(3), 1506. https://doi.org/10.3390/molecules28031506
How many times has this paper been cited?
14 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Molecules: sign in and open the PDF from this page.
Who wrote this paper?
Xiaoyan Yang, Yuan‐Fei Lu, Jianxia Xu, Yongzhong Du, Ri‐Sheng Yu.
What is the DOI of this paper?
10.3390/molecules28031506, permanently at https://doi.org/10.3390/molecules28031506. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.